InsiderFlow

Rebecca Byam

HCWB

Rebecca Byam serves as officer: Chief Financial Officer at HCW Biologics Inc. (HCWB). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

19 trades

$1.46M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$1.46M

Companies Traded

1

HCWB

Active Period

Jul 2021 – May 2026

19 total trades

Most Recent

Buy HCWB

May 27, 2026 · $18.2K

Rebecca Byam's Insider Trading at HCW Biologics Inc. (HCWB)

Buys

19 · $1.46M

Sells

0 · $0.00

Total Shares Bought

508,893

Total Shares Sold

0

HCWB Price Chart
Loading chart...
DateTypeValue
May 27, 2026 Buy$18.2K
May 7, 2025 Buy$220.0K
Sep 15, 2023 Buy$10.5K
Sep 13, 2023 Buy$20.7K
Sep 8, 2023 Buy$19.9K
Sep 7, 2023 Buy$9.7K
Jun 9, 2023 Buy$41.3K
Jun 8, 2023 Buy$51.0K
Jun 7, 2023 Buy$68.1K
May 31, 2023 Buy$65.5K
May 24, 2023 Buy$91.1K
Sep 15, 2022 Buy$38.7K
Sep 14, 2022 Buy$78.4K
Sep 1, 2022 Buy$43.9K
Aug 30, 2022 Buy$51.0K
Aug 26, 2022 Buy$229.7K
Jun 15, 2022 Buy$160.8K
Aug 23, 2021 Buy$44.0K
Jul 23, 2021 Buy$200.0K